These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Therapy of refractory pemphigus vulgaris with monoclonal anti-CD20 antibody (rituximab).
    Author: Morrison LH.
    Journal: J Am Acad Dermatol; 2004 Nov; 51(5):817-9. PubMed ID: 15523367.
    Abstract:
    Three patients with refractory pemphigus vulgaris improved after rituximab, an anti-CD20 monoclonal antibody directed against B cells. Treatment was well tolerated immediately, but one patient developed fatal pneumocystis carinii pneumonia. Serious infections have occurred in several pemphigus patients treated with rituximab and immunosuppressive medications, warranting further evaluation of risk-benefit ratio.
    [Abstract] [Full Text] [Related] [New Search]